Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.2952
+0.0026 (0.89%)
At close: May 12, 2025, 4:00 PM
0.3300
+0.0348 (11.79%)
After-hours: May 12, 2025, 7:58 PM EDT
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $77.91 million as of May 12, 2025. Its market cap has decreased by -70.78% in one year.
Market Cap
77.91M
Enterprise Value
750.72K
1-Year Change
-70.78%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since March 31, 2016, Adaptimmune Therapeutics's market cap has decreased from $575.60M to $77.91M, a decrease of -86.46%. That is a compound annual growth rate of -19.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 75.40M | -45.32% |
| Dec 31, 2024 | 137.90M | -23.43% |
| Dec 29, 2023 | 180.10M | -24.71% |
| Dec 30, 2022 | 239.20M | -59.17% |
| Dec 31, 2021 | 585.90M | -29.78% |
| Dec 31, 2020 | 834.40M | 561.17% |
| Dec 31, 2019 | 126.20M | -79.02% |
| Dec 31, 2018 | 601.40M | -3.93% |
| Dec 29, 2017 | 626.00M | 118.35% |
| Dec 30, 2016 | 286.70M | -50.19% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |